A carregar...
The Law and Ethics of Switching from Biologic to Biosimilar in Canada
Governments and financial institutions in several jurisdictions are planning or implementing nonmedical/‘forced’ switches by cutting drug coverage for reference biologics and funding only less expensive biosimilars. Switches raise numerous ethical and legal challenges, as the drugs are framed as not...
Na minha lista:
| Publicado no: | J Can Assoc Gastroenterol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7465550/ https://ncbi.nlm.nih.gov/pubmed/32905067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz043 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|